Literature DB >> 22761296

Sensitivity and specificity of an operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity.

María Flores-Chavez1, Israel Cruz, Javier Nieto, Teresa Gárate, Miriam Navarro, Ana Pérez-Ayala, Rogelio López-Vélez, Carmen Cañavate.   

Abstract

Trypanosoma cruzi infection is an imported parasitic disease in Spain, and the majority of infected individuals are in the chronic phase of the disease. This study evaluated the sensitivity and specificity of the Operon immunochromatographic test (ICT-Operon; Simple Stick Chagas and Simple Chagas WB [whole blood]; Operon S.A., Spain) for different biological samples. Well-characterized serum samples were obtained from chagasic patients (n = 63), nonchagasic individuals (n = 95), visceral leishmaniasis patients (n = 38), and malaria patients (n = 55). Noncharacterized specimens were obtained from Latin American immigrants and individuals at risk with a clinical and/or epidemiological background: these specimens were recovered serum or plasma samples (n = 450), whole peripheral blood (n = 94), and capillary blood (n = 282). The concordance of the results by enzyme-linked immunosorbent assay and indirect immunofluorescence test was considered to be the "gold standard" for diagnosis. Serum and plasma samples were analyzed by Stick Chagas, and whole blood was analyzed by Simple Chagas WB. The sensitivity and specificity of the ICT-Operon in well-characterized samples were 100% and 97.9%, respectively. No cross-reactivity was found with samples obtained from visceral leishmaniasis patients. In contrast, a false-positive result was obtained in 27.3% of samples from malaria patients. The sensitivities of the rapid test in noncharacterized serum or plasma, peripheral blood, and capillary blood samples were 100%, 92.1%, and 86.4%, respectively, while the specificities were 91.6%, 93.6%, and 95% in each case. ICT-Operon showed variable sensitivity, depending on the kind of sample, performing better when serum or plasma samples were used. It could therefore be used for serological screening combined with any other conventional test.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761296      PMCID: PMC3428388          DOI: 10.1128/CVI.00227-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

1.  Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010.

Authors:  M Navarro; A Perez-Ayala; A Guionnet; J A Perez-Molina; B Navaza; L Estevez; F Norman; M Flores-Chavez; R Lopez-Velez
Journal:  Euro Surveill       Date:  2011-09-22

2.  Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report.

Authors:  R Villalba; G Fornés; M A Alvarez; J Román; V Rubio; M Fernández; J M García; M Viñals; A Torres
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

3.  Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi.

Authors:  Alejandro O Luquetti; Carlos Ponce; Elisa Ponce; Javan Esfandiari; Alejandro Schijman; Susana Revollo; Nestor Añez; Bianca Zingales; Rafael Ramgel-Aldao; Antonio Gonzalez; Mariano J Levin; Eufrosina S Umezawa; José Franco da Silveira
Journal:  Diagn Microbiol Infect Dis       Date:  2003-08       Impact factor: 2.803

4.  [Utility of an immunochromatographic test for Chagas disease screening in primary healthcare].

Authors:  Paulo López-Chejade; Carme Roca; Elizabeth Posada; María Jesús Pinazo; Joaquim Gascon; Monserrat Portús
Journal:  Enferm Infecc Microbiol Clin       Date:  2009-09-23       Impact factor: 1.731

Review 5.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

6.  Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico.

Authors:  Sergio Sosa-Estani; Miriam Rubi Gamboa-León; Jaime Del Cid-Lemus; Fernando Althabe; Jackeline Alger; Olivia Almendares; María L Cafferata; Jean-Philippe Chippaux; Eric Dumonteil; Luz Gibbons; Nicolás Padilla-Raygoza; Dominique Schneider; José M Belizán; Pierre Buekens
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

7.  Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.

Authors:  Raymond L Houghton; Yvonne Y Stevens; Kathryn Hjerrild; Jeff Guderian; Masahiko Okamoto; Mazbahul Kabir; Steven G Reed; David A Leiby; W John W Morrow; Myriam Lorca; Syamal Raychaudhuri
Journal:  Clin Vaccine Immunol       Date:  2009-02-11

8.  Validity of serology for American trypanosomiasis with eluates from filter paper.

Authors:  G L Machado-Coelho; R W Vitor; C de A Chiari; C M Antunes
Journal:  Mem Inst Oswaldo Cruz       Date:  1995 Jan-Feb       Impact factor: 2.743

9.  Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain).

Authors:  Jose Muñoz; Jordi Gómez i Prat; Montserrat Gállego; Fausto Gimeno; Begoña Treviño; Pablo López-Chejade; Oriol Ribera; Lluis Molina; Sergi Sanz; María Jesús Pinazo; Cristina Riera; Elizabeth J Posada; Ginés Sanz; Montserrat Portús; Joaquim Gascon
Journal:  Acta Trop       Date:  2009-03-05       Impact factor: 3.112

10.  Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease.

Authors:  Olga Sánchez Negrette; Fernando J Sánchez Valdéz; Carlos D Lacunza; María Fernanda García Bustos; María Celia Mora; Alejandro D Uncos; Miguel Angel Basombrío
Journal:  Clin Vaccine Immunol       Date:  2007-12-05
View more
  7 in total

1.  Accuracy of a Rapid Diagnostic Test (Cypress Chagas Quick Test®) for the Diagnosis of Chronic Chagas Disease in a Nonendemic Area: A Retrospective Longitudinal Study.

Authors:  Andrea Angheben; Silvia Staffolani; Mariella Anselmi; Stefano Tais; Monica Degani; Federico Gobbi; Dora Buonfrate; Maria Gobbo; Zeno Bisoffi
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

Review 2.  Overcoming research barriers in Chagas disease-designing effective implementation science.

Authors:  Andrés F Henao-Martínez; Kathryn Colborn; Gabriel Parra-Henao
Journal:  Parasitol Res       Date:  2016-10-22       Impact factor: 2.289

3.  Cross-sectional, descriptive study of Chagas disease among citizens of Bolivian origin living in Munich, Germany.

Authors:  Miriam Navarro; Nicole Berens-Riha; Stefan Hohnerlein; Peter Seiringer; Charlotte von Saldern; Sarah Garcia; Teresa Blasco-Hernández; Bárbara Navaza; Jonathan Shock; Gisela Bretzel; Michael Hoelscher; Thomas Löscher; Pedro Albajar-Viñas; Michael Pritsch
Journal:  BMJ Open       Date:  2017-01-16       Impact factor: 2.692

4.  Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis.

Authors:  Andrea Angheben; Dora Buonfrate; Mario Cruciani; Yves Jackson; Julio Alonso-Padilla; Joaquim Gascon; Federico Gobbi; Giovanni Giorli; Mariella Anselmi; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2019-05-31

5.  Development of a New Lateral Flow Assay Based on IBMP-8.1 and IBMP-8.4 Chimeric Antigens to Diagnose Chagas Disease.

Authors:  Edimilson D Silva; Ângelo A O Silva; Emily F Santos; Leonardo M Leony; Natália E M Freitas; Ramona T Daltro; Antônio G P Ferreira; Rafaela L Diniz; Aline R Bernardo; Alejandro O Luquetti; Marco A Krieger; Paola A F Celedon; Pedro A Viñas; Nilson I T Zanchin; Fred L N Santos
Journal:  Biomed Res Int       Date:  2020-08-17       Impact factor: 3.411

6.  Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in serum banks in areas of endemicity and nonendemicity.

Authors:  Claudia L Sánchez-Camargo; Pedro Albajar-Viñas; Patricia P Wilkins; Javier Nieto; David A Leiby; Luc Paris; Karenina Scollo; Carolina Flórez; Carmen Guzmán-Bracho; Alejandro O Luquetti; Nidia Calvo; Kenji Tadokoro; Amadeo Saez-Alquezar; Pedro Pablo Palma; Miguel Martin; Laurence Flevaud
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

7.  Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologies.

Authors:  Esber S Saba; Lucie Gueyffier; Marie-Laure Dichtel-Danjoy; Bruno Pozzetto; Thomas Bourlet; François Gueyffier; Yahia Mekki; Hans Pottel; Ester C Sabino; Philippe Vanhems; Maan A Zrein
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.